James C. Foster
At a glance: James C. Foster is Director at Charles River Laboratories (CRL). Their latest SEC Form 4, filed Oct 26, 2026, reported a sale of $8.4M. On file: 0 purchase lines ($0) and 4 sale lines ($43.3M).
Disclosed holdings: about $10.4M of CRL stock: 31,596 shares reported on their latest Form 4 (filed Oct 26, 2026), valued at the Nov 19, 2026 close of $328.62. This counts only CRL shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Charles River Laboratories International, Inc. (CRL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
James C. Foster's InsiderPrint
6 trades from SEC Form 4 filings, 2023 to 2026, drawn as one fingerprint.
Reading this print: Mostly sells, trading about 2 times a year, typically $8.4M a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (2)
- Dent inward: a sale (4)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- William Spencer MarshallCEO · PL · 98% match
- Adena T. FriedmanCEO, Chair · NDAQ · 98% match
- Richard B. BarkerCFO · NE · 97% match
- Sassine GhaziCEO, President · SNPS · 96% match
- Bren D. HigginsCFO · KLAC · 96% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2023
From the SEC's insider data sets: each open-market buy by James C. Foster, matched to how the stock did over the next 90 days against the S&P 500.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 26SEC | CRLCharles River Laboratories International, Inc. | Sell Plan | 24,04231,596 held (−43%) | $350.00 | $8.4M | -6.1% |
| Aug 27SEC | CRLCharles River Laboratories International, Inc. | Sell Plan | 33,56131,596 held (−52%) | $300.00 | $10.1M | +9.5% |
| Aug 11SEC | CRLCharles River Laboratories International, Inc. | Sell Plan | 28,73331,596 held (−48%) | $275.00 | $7.9M | +19.5% |
| Jul 1SEC | CRLCharles River Laboratories International, Inc. | Sell Plan | 75,00031,596 held (−70%) | $225.00 | $16.9M | +46.1% |
- Sell
Director James C Foster sold $8.4M of CRL at $350.00 — cuts the stake by 43%; pre-scheduled 10b5-1 plan sale.
- Sell
Director James C Foster sold $10.1M of CRL at $300.00 — cuts the stake by 52%; pre-scheduled 10b5-1 plan sale.
- Sell
Director James C Foster sold $7.9M of CRL at $275.00 — cuts the stake by 48%; pre-scheduled 10b5-1 plan sale.
- Sell
Director James C Foster sold $16.9M of CRL at $225.00 — cuts the stake by 70%; pre-scheduled 10b5-1 plan sale.
Follow James C. Foster
Get one email when James C. Foster files a new purchase or sale. Free.
At most one email a day about James C. Foster, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.